Latest article
U.S. FDA declines to approve Provention Bio’s diabetes drug
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
“Bunny Hop” Bike Experience and health occasions round Houston
Ana Khan, Employed authorMarch 25, 2021 Updated: March 25, 2021, 12 noon
...
UK Diabetes Insulin Supply Pens Market Measurement | Business Evaluation and Alternative Evaluation 2021-2027
Pune, Maharashtra, India, March 11, 2021 (Wiredrelease) Brandessence Market Research and Consulting...